Fosfomycin for Multidrug Treatment of Klebsiella pneumoniae Carbapenemase Bacteremia

Abstract

Get full access to this article

View all access options for this article.

References

Hirsch

Guo

Chang

. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. J Infect Dis. 2013;207:786-793.

Sbrana

Malacarne

Viaggi

. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit. Clin Infect Dis. 2013;56:697-700.

Falgas

Kanellopoulou

Karageorgopoulos

. Antimicrobial susceptibility of multi-drug resistant Gram-negative bacteria to fosfomycin. Eur J Clin Microbiol Infect Dis. 2008;27:439-443.

Michalopoulos

Virtzili

Rafailidis

Chalevelakis

Damala

Falagas

. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumonia in critically ill patients: a prospective evaluation. Clin Microbiol Infect. 2010;16:184-186.

Monurol [package insert]. St Louis, MO: Forest Pharmaceuticals, Inc; 2011.